Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-dose Intravenous Methylprednisolone Therapy in Patients With Graves' Orbitopathy is Associated With the Increased Activity of Factor VIII

NCT03535090 is registered in ClinicalTrials.gov with Piotr Miskiewicz as lead sponsor.

NCT NCT03535090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03535090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-dose Intravenous Methylprednisolone Therapy in Patients With Graves' Orbitopathy is Associated With the Increased Activity of Factor VIII
Lead sponsor
Piotr Miskiewicz
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
December 31, 2014
Enrollment
26 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blood coagulation, graves ophthalmopathy, graves' disease, venous thromboembolism